Does DPA contribute to omega-3 status and promote resolution of inflammation?

Docosapentaenoic acid (DPA) is an essential, though often overlooked, long-chain omega-3 fatty acid that plays a significant role in human metabolism and the resolution of inflammation. While clinical focus frequently centers on eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), research confirms that DPA serves as both a metabolic bridge and a potent bioactive precursor in its own right.

Clinical effectiveness and status

DPA is a substantial component of the total omega-3 pool, with circulating levels often comparable to EPA in plasma and tissues.

• Contribution to Status: Large-scale cohort analyses, such as NHANES, include DPA when assessing the protective effects of omega-3s on mortality and metabolic health. In human plasma, DPA typically accounts for 1–3% of total fatty acids.
• Interconversion: DPA and EPA are linked via a bidirectional metabolic pathway. EPA is elongated to DPA by the enzyme ELOVL5, while DPA can undergo retroconversion back to EPA via peroxisomal beta-oxidation. This suggests that DPA helps maintain the homeostatic balance of long-chain omega-3 substrates.

Mechanistic pro-resolving signaling

DPA is not merely a storage molecule; it is a primary substrate for Specialized Pro-resolving Mediators (SPMs), which are critical for "switching off" the inflammatory response.

• Unique Metabolites: DPA is enzymatically converted by lipoxygenases (12-LOX, 15-LOX) and COX-2 into its own distinct families of mediators, including D-series resolvins (RvD(n-3 DPA)), protectins (PD(n-3 DPA)), and maresins (MaR(n-3 DPA)).
• Signaling Action: These DPA-derived SPMs act as potent agonists on G-protein-coupled receptors. Mechanistic studies demonstrate they limit neutrophil infiltration, enhance the clearance of cellular debris (efferocytosis), and suppress pro-inflammatory cytokines such as TNF-α and IL-6.

Clinical implications

For an individual looking to optimize their omega-3 status, understanding DPA is vital for a comprehensive view of inflammatory health.

• Beyond EPA/DHA: Standard "Omega-3 Index" tests that only measure EPA and DHA may underestimate an individual’s total anti-inflammatory capacity if DPA levels are not considered.
• Tissue Homeostasis: Because DPA can be retro-converted to EPA and serves as a precursor for unique SPMs, it provides a flexible reservoir that the body can draw upon to resolve acute inflammation and promote tissue repair.

Bottom line

DPA is a scientifically validated member of the omega-3 family that contributes to total fatty acid status, interconverts with EPA, and serves as a critical substrate for unique pro-resolving mediators that actively terminate inflammation.